Valvular heart disease in women

Current Cardiovascular Risk Reports

Volumn 2, Issue 3, 2008, Pages 217-226

  Maganti, Kameswari ^a   Rigolin, Vera H ^b   Bonow, Robert O ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873516856     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-008-0041-0     Document Type: Review

References (63)

1. Bonow RO, Carabello BA, Chatterjee K, et al.: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006, 48: e1-e148.
2. Vahanian A, Baumgartner H, Bax J, et al.: Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007, 28: 230-268.
3. Zoghbi WA, Enriquez-Sarano M, Foster E, et al.: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003, 16: 777-802.
4. Otto CM: Textbook of Clinical Echocardiography, edn 3. Philadelphia: Elsevier/Saunders; 2004.
5. Rajamannan NM, Bonow RO, Rahimtoola SH: Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med 2007, 4: 254-262.
6. Lindroos M, Kupari M, Heikkila J, Tilvis R: Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993, 21: 1220-1225.
7. Roberts WC, Ko JM: Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005, 111: 920-925.
8. Freeman RV, Otto CM: Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005, 111: 3316-3326.
9. Otto CM: Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 2006, 47: 2141-2151.
10. Fedak PWM, Verma S, David TE, et al.: Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002, 106: 900-904.
11. Roberts WC: The congenitally bicuspid aortic valve: a study of 85 autopsy cases. Am J Cardiol 1970, 26: 72-83.
12. Roberts WC, Morrow AG, McIntosh CL, et al.: Congenitally bicuspid aortic valve causing severe, pure aortic regurgitation without superimposed infective endocarditis. Analysis of 13 patients requiring aortic valve replacement. Am J Cardiol 1981, 47: 206-209.
13. Douglas PS, Otto CM, Mickel MC, et al.: Gender differences in left ventricular geometry and function in patients undergoing balloon dilation of the aortic valve for isolated aortic stenosis. Br Heart J 1995, 73: 548-554.
14. Aurigemma GP, Gaasch WH: Gender differences in older patients with pressure-overload hypertrophy of the left ventricle. Cardiology 1995, 86: 310-317.
15. Lancellotti P, Lebois F, Simon M, et al.: Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005, 112: I377-I382.
16. Das P, Rimington H, Chambers J: Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005, 26: 1309-1313.
17. Edwards FH, Peterson ED, Coombs LP, et al.: Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001, 37: 885-892.
18. Ambler G, Omar R Z, Royston P, et al.: Generic, simple risk stratification model for heart valve surgery. Circulation 2005, 112: 224-231.
19. Birkmeyer JD, Siewers AE, Finlayson EV, et al.: Hospital volume and surgical mortality in the United States. N Engl J Med 2002, 346: 1128-1137.
20. Caulfield MT, Budoff MJ, Takasu J, et al.: Angiotensin converting enzyme inhibitor use is associated with a decreased rate of aortic valve calcium accumulation [abstract]. Circulation 2002, 106(Suppl II): II-640.
21. O'Brien KD, Probstfield JL, Caulfield MT, et al.: Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 2005, 165: 858-862.
22. Rosenhek R, Rader F, Loho N, et al.: Statins but not ACE-inhibitors delay progression of aortic stenosis. Circulation 2004, 110: 1291-1295.
23. Cowell SJ, Newby DE, Prescott RJ, et al.: A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005, 352: 2389-2397.
24. Pibarot P, Dumesnil JG: Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart 2006, 92: 1022-1029.
25. Marcheix B, Lamarche Y, Berry C, et al.: Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg 2007, 134: 1150-1156.
26. Munt B, Webb J: Percutaneous valve repair and replacement techniques. Heart 2006, 92: 1369-1372.
27. Roberts WC, Ko JM, Moore TR, et al.: Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 2006, 114: 422-429.
28. Onorati F, De Santo LS, Carozza A, et al.: Marfan syndrome as a predisposing factor for traumatic aortic insufficiency. Ann Thorac Surg 2004, 77: 2192-2194.
29. Pretre R, Faidutti B: Surgical management of aortic valve injury after nonpenetrating trauma. Ann Thorac Surg 1993, 56: 1426-1431.
30. Klodas E, Enriquez-Sarano M, Tajik JA, et al.: Surgery for aortic regurgitation in women: Contrasting indications and outcomes as compared with men. Circulation 1996, 94: 2472-2478.
31. Dujardin KS, Enriquez-Sarano M, Schaff HV, et al.: Mortality and morbidity of aortic regurgitation in clinical practice: a long-term follow-up study. Circulation 1999, 99: 1851-1857.
32. Bonow RO, Lakatos E, Maron BJ, et al.: Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991, 84: 1625-1635.
33. Borer JS, Hochreiter C, Herrold EM, et al.: Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 1998, 97: 525-534.
34. Detaint D, Messika-Zeitoun D, Maalouf F, et al.: Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation. J Am Coll Cardiol Img 2008, 1: 1-11.
35. Carroll JD, Gaasch WH, Zile MR, et al.: Serial changes in left ventricular function after correction of chronic aortic regurgitation: dependence on early changes in preload and subsequent regression of hypertrophy. Am J Cardiol 1983, 51: 476-482.
36. Bonow RO, Dodd JT, Maron BJ, et al.: Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation 1988, 78: 1108-1120.
37. Scognamiglio R, Rahimtoola SH, Fasoli G, et al.: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function [see comments]. N Engl J Med 1994, 331: 689-694.
38. Evangelista A, Tornos P, Sambola A, et al.: Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005, 353: 1342-1349.
39. Carapetis JR: Rheumatic heart disease in developing countries. N Engl J Med 2007, 357: 439-441.
40. Carabello BA, Grossman W: Calculation of stenotic valve orifice area. In Grossman's Cardiac Catheterization, Angiography, and Intervention, edn 6. Edited by Baim DS, Grossman W. Philadelphia: Lippincott Williams & Wilkins; 2000.
41. Gash AK, Carabello BA, Cepin D, Spann JF: Left ventricular ejection performance and systolic muscle function in patients with mitral stenosis. Circulation 1983, 67: 148-154.
42. Carabello BA: Modern management of mitral stenosis. Circulation 2005, 112: 432-437.
43. Iung B, Garbarz E, Doutrelant L, et al.: Late results of percutaneous mitral commissurotomy for calcific mitral stenosis. Am J Cardiol 2000, 85: 1308-1314.
44. Reyes VP, Raju BS, Wynne J, et al.: Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994, 331: 961-967.
45. Ben Farhat M, Ayari M, Maatouk F, et al.: Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. Circulation 1998, 97: 245-250.
46. Cardoso LF, Grinberg M, Rati MA, et al.: Comparison between percutaneous balloon valvuloplasty and open commissurotomy for mitral stenosis: a prospective and randomized study. Cardiology 2002, 98: 186-190.
47. Wilkins GT, Weyman AE, Abascal VM, et al.: Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilation. Br Heart J 1988, 60: 299-308.
48. Reid CL, Otto CM, Davis KB, et al.: Influence of mitral valve morphology on mitral balloon commissurotomy: immediate and six-month results from the NHLBI Balloon Valvuloplasty Registry. Am Heart J 1992, 124: 657-665.
49. Dajani AS, Taubert KA, Wilson W, et al.: Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997, 96: 358-366.
50. Rosen SE, Borer JS, Hochreiter C, et al.: Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol 1994, 74: 374-380.
51. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al.: Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005, 352: 875-883.
52. Rosenhek R, Rader F, Klaar U, et al.: Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006, 113: 2238-2244.
53. Iung B: Management of ischaemic mitral regurgitation. Heart 2003, 89: 459-464.
54. Tepe NA, Edmunds LH Jr: Operation for acute postinfarction mitral insufficiency and cardiogenic shock. J Thorac Cardiovasc Surg 1985, 89: 525-530.
55. Rankin JS, Hickey MS, Smith LR, et al.: Ischemic mitral regurgitation. Circulation 1989, 76(6 Pt 2): I116-I121.
56. Hickey MS, Smith LR, Muhlbaier LH, et al.: Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation 1988, 78(3 Pt 2): I51-I59.
57. Replogle RL, Campbell, CD: Surgery for mitral regurgitation associated with ischemic heart disease. Results and strategies. Circulation 1989, 79(6 Pt 2): I122-I125.
58. Soler-Soler J, Galve E: Worldwide perspective of valve disease. Heart 2000, 83: 721-725.
59. Lesniak-Sobelga A, Tracz W, KostKiewicz M, et al.: Clinical and echocardiographic assessment of pregnant women with valvular heart diseases-maternal and fetal outcome. Int J Cardiol 2004, 94: 15-23.
60. Hameed A, Karaalp IS, Tummala PP, et al.: The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001, 37: 893-899.
61. Gei AF, Hankins GD: Cardiac disease and pregnancy. Obstet Gynecol Clin North Am 2001, 28: 465-512.
62. Silversides C, Coleman J, Sermaer M, et al.: Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol 2003, 91: 1386-1389.
63. Sawhney H, Aggarwal N, Suri V, et al.: Maternal and perinatal outcome in rheumatic heart disease. Int J Gynaecol Obstet 2003, 80: 9-14.